• Venture Capital Needed to Fill Gaps Left by Uncertain Government Funding

    Mar 11 | Bio-IT World| Altitude Lab, the nonprofit formed by clinical-stage biotech company Recursion, recently launched a pre-seed venture fund to help 10 to 15 early-stage startups get through the current “period of uncertainty” around government funding—and other private investment groups will ideally follow suit over the short term. More

  • Pan-European Genomic Reanalysis Effort Yields Over 500 Diagnoses

    Mar 06 | Bio-IT World| A groundbreaking collaborative effort spanning 12 European countries and Canada has successfully identified genetic causes for more than 500 previously unsolved rare disease cases. Led by the University of Tübingen in Germany, the Solve-RD (Solving the Unsolved Rare Diseases) consortium brought together 300 experts from 37 institutions to leverage advanced genomic reanalysis techniques, ultimately providing long-awaited answers to patients and their families. More

  • High-Performance Computing in the AI Era: Challenges and Future Prospects

    Mar 05 | Bio-IT World| In an era where artificial intelligence (AI) dominates discussions in technology, high-performance computing (HPC) remains the backbone of scientific discovery and enterprise research. Despite its critical role, HPC often operates in the background, much like electricity—only noticed when it fails. On the latest Trends from the Trenches Podcast, Dirk Petersen, Director of the Supercomputing Center at Oregon State University, shared his insights on the evolving role of HPC and its integration into AI-driven research. More

  • AI to Democratize Access to Cheap, High-Throughput Cardiotoxicity Testing

    Mar 04 | Bio-IT World| Researchers have trained an artificial intelligence (AI) model to reconstruct the electrical signals inside of heart cells based on recordings taken from outside those cells, opening the possibility of cheap, high-yielding cardiotoxicity testing using commercially available microelectrode arrays. The hope is that the U.S. Food and Drug Administration (FDA) will allow the tool to be used in lieu of inserting pipettes into cells to record signaling changes with the addition of a drug, which is both costly and cumbersome to do at scale. More

  • The False Dichotomy of Short Reads vs. Long Reads

    Feb 28 | Bio-IT World| The rate of evolution of DNA sequencing technologies since the introduction of the Sanger method in the 1970s has been astounding. It’s just over 20 years since the publication of the first draft human genome and today, technologies can deliver that same information for as little as $100. More

  • RNA in Oncology Research, Ultima Genomics Commercially Launches Platform, More

    Feb 27 | Bio-IT World| InfoBionic.Ai’s MoMe ARC delivers real-time cardiac insights, empowering physicians to improve patient outcomes; Ultima Genomics announced the commercial launch of UG 100 Solaris; and more. More

  • Follow the Money: 3D Spatial Biology, AI-Powered Imaging Biomarkers, More

    Feb 26 | Bio-IT World| Stellaromics commercializes their 3D spatial biology platform, Pyxa; Latent Labs’ AI platform shows promising potential to open new paths to personalized medicines; and more. More

  • Eli Lilly’s CISO Andrea Abell on Safeguarding Innovation in Pharma

    Feb 20 | Bio-IT World| Earlier this week at the ViVE conference in Nashville, Tenn., Bio-IT World editor, Allison Proffitt, sat down with Andrea Abell, Eli Lilly’s Chief Information Security Officer (CISO), whose mission is to protect the integrity of pharmaceutical research from inception to patient delivery. Together they discussed the critical role cybersecurity plays in Lilly’s broader goal of bringing life-changing medicines to market. More

  • Illumina’s New Spatial Products

    Feb 19 | Bio-IT World| Today, Illumina announced a new spatial technology program of Illumina sequencers and a multimodal analysis platform. The company also announced a collaboration with the Broad Institute on spatial transcriptomics. Illumina's spatial technology delivers unbiased whole-transcriptome profiling with cellular resolution and high sensitivity. More

  • AI in Healthcare: How To Assess What Works

    Feb 18 | Bio-IT World| At a panel discussion this week at the ViVE conference in Nashville, Tenn., researchers and physicians discussed the promise and hype of AI. Moderated by Alexander Morgan, partner at Khosla Ventures, the discussion was wide ranging and discussed the AI tools ready for use by physicians; which classes of AI are not yet delivering; and how to assess what’s right for you. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!